Close

Sorrento Announces (SRNE) Reports Investment, Collaboration With Nantworks Founder Dr. Patrick Soon-Shiong

December 15, 2014 9:29 AM EST Send to a Friend
Sorrento Therapeutics, Inc. (NASDAQ: SRNE) announced today that it has entered into a binding agreement with NantWorks founder, physician scientist ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login